Webinar: Monday, 22 March 2022, 7:15 PM

Baricitinib: a new and approved treatment option to reduce mortality in hospitalised patients with Covid-19 patients who require supplementation oxygen.

Join Specialist Forum and medical fellow, Dr Stefan Wilhelm for a one-hour free CPD-accredited webinar to learn more about Baricitinib, a new and approved treatment option in patients who are hospitalised for COVID-19 and who require supplemental oxygen. This webinar is sponsored by Eli Lilly

Presented by
Rene Bosman

Rene Bosman

  • Editor: Specialist Forum
Dr Stefan Wilhelm

Dr Stefan Wilhelm

  • Medical Fellow Global-International Business Unit, Go-to-Patient Anti COVID19 Therapies
Dr Wilhelm completed his medical studies at the Universities of Hamburg, and the Ludwig-Maximilians-Universität in Munich, Germany in 1993. In 1999 he completed his training as an emergency physician and in 2004 he completed his residency training programme in anaesthesiology. He joined Eli Lilly in September 2004 as a clinical research physician and was subsequently promoted to medical fellow.

116 professionals have already registered.


Webinar Registration

By registering for this webinar, you agree to our Terms & Conditions.

New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.

Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.

Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za